BRIEF: Sichuan Biokin launches Hong Kong IPO, eyes Stock Connect program entry
Biopharmaceutical company Sichuan Biokin Pharmaceutical (2615.HK; 688506.SH) launched its Hong Kong IPO on Friday, aiming to raise up to HK$3.36 billion ($432 million) by selling 8.63 million shares for between…
BRIEF: GenFleet shares double in heavily oversubscribed IPO
Shares of biopharmaceutical firm GenFleet Therapeutics (Shanghai) Inc. (2595.HK) opened up 116% in their Hong Kong trading debut on Friday, and held on to the gains to close up more…
RemeGen’s $4.2 billion licensing deal falls flat with investors
The biopharma firm had fanned excitement over a rights deal for its autoimmune drug but the eventual terms, with just a small portion of upfront cash, left the market disappointed…
Dispute over Covid vaccines casts doubt on Clover Bio recovery
The Chinese biopharma firm faces a potentially damaging fight over a $224 million upfront payment it received in an ill-fated deal to supply Covid vaccines Key Takeaways: The Gavi international…
BeiGene heads for profit milestone after hemorrhaging cash
With a blockbuster drug under its belt and another product approved for U.S. sale, the biopharma firm says it is on track to post an annual operating profit this year…
I-Mab Shaken by Management Moves, Merger Talk and Delisting Threat
Cancer drug maker has been in a wide range of market-moving headlines lately, though its stock still trades near an all-time low Key Takeaways: I-Mab was placed on a list…
Recent Articles
RemeGen’s $4.2 billion licensing deal falls flat with investors
9995.HK
688331.SHG
BeiGene heads for profit milestone after hemorrhaging cash
6160.HK
ONC.US
688235.SHG
RELATED ARTICLES
-
Sichuan Teway spices up Hong Kong’s hot IPO market
603317.SHG -
Unisound launches modest IPO into crowded Hong Kong market
9678.HK
-
Helmed by new chairman, Best Mart 360 navigates changing Hong Kong landscape
2360.HK
- Intsig scans global financial markets for cash with Hong Kong IPO
-
BRIEF: Zenergy included in program making its stock available to Mainland China investors
3677.HK
-
Fibocom limps out of IPO gate, weighed down by sagging margins
0638.HK 300638.SHE
-
JD.com sets up Hong Kong bridgehead as real-time retail battle moves overseas
9618.HK JD.US
